Data will be presented highlighting the use of GENESIS to create genetically defined 'X-MAN' (gene X, mutant and normal) human isogenic cell-line pairs, which accurately model specific genetic variations present in a defined cancer patient population, and provide a matched normal genetic background for reference, in key application areas. First, defining the core phenotype driven by specific cance